HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical features of Pittsburgh compound-B-negative dementia.

AbstractBACKGROUND/AIMS:
We previously found that some cases of clinically diagnosed Alzheimer's disease (AD) were rated as Pittsburgh compound B (PiB) negative by amyloid imaging (i.e. cases of PiB-negative dementia). The present study was designed to analyze the clinical features of PiB-negative dementia patients in detail.
METHODS:
Of the 64 cases of clinically diagnosed AD, 14 were rated PiB negative. Eleven of these were further analyzed using CSF biomarker levels and findings from MRI, FDG-PET, (123)I-MIBG myocardial scintigraphy and voxel-based morphometry (VBM).
RESULTS:
When examined by (123)I-MIBG myocardial scintigraphy, the heart/mediastinum ratio was significantly higher in the PiB-negative dementia group than in the dementia with Lewy bodies (DLB) group. Analyses of CSF biomarkers and MRI and FDG-PET findings suggested argyrophilic grain disease (AGD) in 3 cases, frontotemporal lobar degeneration (FTLD) in 3 cases, neurofibrillary tangle-predominant dementia (NFTD) in 1 case, and AD in 2 cases. In the VBM data analysis, the PiB-positive AD group showed significant atrophy of both hippocampi compared with the healthy control group, while the PiB-negative dementia group presented with significant atrophy of the left precuneus.
CONCLUSION:
PiB-negative dementia is unlikely to include DLB, while it most likely includes diseases of tauopathy, such as FTLD, AGD and NFTD. A better understanding of PiB-negative dementia is expected to further improve the accuracy of the clinical AD diagnosis.
AuthorsJun Takeuchi, Hiroyuki Shimada, Suzuka Ataka, Joji Kawabe, Hiroshi Mori, Kei Mizuno, Yasuhiro Wada, Susumu Shiomi, Yasuyoshi Watanabe, Takami Miki
JournalDementia and geriatric cognitive disorders (Dement Geriatr Cogn Disord) Vol. 34 Issue 2 Pg. 112-20 ( 2012) ISSN: 1421-9824 [Electronic] Switzerland
PMID22947919 (Publication Type: Journal Article)
CopyrightCopyright © 2012 S. Karger AG, Basel.
Chemical References
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Thiazoles
  • tau Proteins
  • Fluorodeoxyglucose F18
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (diagnosis, metabolism)
  • Amyloid beta-Peptides (cerebrospinal fluid)
  • Aniline Compounds (metabolism)
  • Case-Control Studies
  • Dementia (diagnosis, metabolism)
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Iodine Radioisotopes
  • Lewy Body Disease (diagnosis, metabolism)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardial Perfusion Imaging
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Thiazoles (metabolism)
  • tau Proteins (cerebrospinal fluid)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: